Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Look no further than Boeing to see what happens to a company that puts profit over quality. Sad to see.
Meanwhile, the tech geniuses at Airbus are making hay with some excellent and innovative airplanes.
Riesgo - listen again to the final answer of the Q&A session. The company have always provided guidance based on the best information they have at the time. They do not have a crystal ball. And you cannot legislate for key stakeholders / customers switching tracks mid product development. Neither can you anticipate delays caused by third party screw ups. Of course, they could have projected a less optimistic timeline. But how much of the delay is due to the inconsistencies of our main potential customer - HMG? I can only imagine the frustrations in dealing with BoJo’s lackeys. But today’s presentation also demonstrates the board are able to make shrewd business decisions (dropping BBI).
There’s a limit to anyone’s patience, but when the product is best-in-class, it’s worth investing in. The market is currently reacting to the slow, but short-term, sales progress of the AffiDx LFT. As someone already pointed out, we’ve yet to break the chains of the current global suppliers, Innova. Fortunately, the outlook isn’t entirely rosy for them. Our govt thinks it is beyond reproach and continues to order them, but not for much longer I suspect. Outside of the State, good luck convincing paying customers to use your business if you can’t demonstrate a Covid safe workplace. I can imagine the lawyers having field day if class actions were brought against a business / employer for relying on a bogus Covid test when other, more accurate tests are available.
I’ve been a PM. I’ve dealt with multiple stakeholders. I’ve drawn up the Gantt charts, knocked on doors, tested the product, written the guidance, re-written the Gantt charts to reflect real-world timescales... I’ve made the tea, coffee and put the biscuits out and cleared up after the meetings were over and done almost everything in between. And after finally signing off on the ‘product’, I realised nothing is ever as straightforward as it looks. Multiple moving parts, multiple injects, you can never anticipate them all. The best you can do is keep the whole circus moving in the right direction. Which is clearly where we are after the presentation. And why I’ve never hyperventilated about missed deadlines. Long term, this is a fantastic prospect.
/Probably because I’m distinctly average, but you get the point
Indeed. As did the comment about anyone with knowledge of managing projects. Life / the world isn’t a perfect place where everything happens as advertised. Despite what certain LSE posters would have you believe.
Steady progress in the right direction across all fronts.
I have considered the lag time from offering the test to the market to initial supply. Necessarily, the test had to complete CV for CE marking / MHRA approval. That was only a handful of trading sessions ago.
The fact that the test was thereafter immediately for sale does not and can not mean boxes of AffiDx would fly off the shelves the next day. Any contract would require forward projection of orders and the assurance to supply them. As the nascent U.K. LFT industry is still spinning up, that’s a question that will take a bit of time to answer.
Notwithstanding all the nonsense going on at PD and the possible U.K. Govt involvement, the test is on the market and now it’s a question of supply before final contracts can be inked.
Imagine say, Aston Martin developed an affordable car that was in great demand, worldwide. It was widely regarded as the Best Car In The World and everyone wanted one - and it could be produced in the millions. Firstly, nobody would put an order in until it had been *proven* to be the best. Because there were many similar cars out there that claimed to be The Best. Furthermore, until they could *guarantee* how many they could roll off the conveyor belt every month, contracts would be impossible to draw up for dealerships. Especially difficult as the global dealership networks were all showing interest.
The CV data demonstrates we have The Best Test. The global demand is there. The competition has been thrown in the trash. What we must be dealing with here is how big is the queue to get our test and when can we start rolling them off the production lines in the quantities desired. Fascinating stuff.
Just some Covid news as a reminder this isn’t going anywhere. Approximately 10% of the world has been vaccinated as the super contagious Delta variant takes over. Countries are seeing local cases appear despite lockdowns and travel bans. Previously unaffected countries seeing the Delta variant starting to emerge. The market for testing remains huge and likely will remain so for the next 18-24 months. Some headlines from the Reuters app - the evidence is out there and readily available:
Brazil set to pass half a million COVID-19 deaths
Cambodia reports 20 deaths from COVID, record for single day
Shenzhen airport tightens COVID-19 measures as China logs 30 new cases
Australia's largest state records two new local COVID-19 cases
Biden, Harris urge vaccinations as U.S. looks likely to miss July 4 target
Uganda imposes new anti-coronavirus measures to stem raging pandemic
Delta COVID variant becoming globally dominant, WHO official says
Kremlin blames vaccine hesitancy as Delta variant drives Moscow surge
Three-day COVID travel ban in force in Lisbon as Delta variant spreads
Sometimes daily for work. Otherwise twice weekly with Innova’s test at home. Which I have subsequently stopped doing and reporting the results online. If I feel symptomatic, I might take one out of the naughty drawer to check